High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

Author： Met Özcan   Balslev Eva   Flyger Henrik   Svane Inge  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.125, Iss.2, 2011-01, pp. : 395-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

By Svane Inge   Pedersen Anders   Johnsen Hans   Nielsen Dorte   Kamby Claus   Gaarsdal Eva   Nikolajsen Kirsten   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 633-641

Springer Publishing Company

Access to resources Recommend Favorite

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

By Kyte Jon   Kvalheim Gunnar   Lislerud Kari   thor Straten Per   Dueland Svein   Aamdal Steinar   Gaudernack Gustav  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 5, 2007-05 ,pp. : 659-675

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

By Svane Inge   Pedersen Anders   Johansen Julia   Johnsen Hans   Nielsen Dorte   Kamby Claus   Ottesen Svend   Balslev Eva   Gaarsdal Eva   Nikolajsen Kirsten   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1485-1499

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cells are dysfunctional in patients with operable breast cancer

By Satthaporn Sukchai   Robins Adrian   Vassanasiri Wichai   El-Sheemy Mohamed   Jibril Jibril   Clark David   Valerio David   Eremin Oleg  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 510-518

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

By Pliarchopoulou K.   Kalogeras K.   Kronenwett R.   Wirtz R.   Eleftheraki A.   Batistatou A.   Bobos M.   Soupos N.   Polychronidou G.   Gogas H.   Samantas E.   Christodoulou C.   Makatsoris T.   Pavlidis N.   Pectasides D.   Fountzilas G.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite